1,811 results on '"Recurrent glioblastoma"'
Search Results
2. Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM (SONOBIRD)
3. A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM (FRONTIER)
4. Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma
5. ASP8374 + Cemiplimab in Recurrent Glioma
6. BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas (PNOC017)
7. Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer
8. Randomized Study of Neo-adjuvant and Adjuvant Pembrolizumab With and Without Targeted Blood Brain Barrier Opening Using Exablate MRI-guided Focused Ultrasound (Exablate MRgFUS) for Recurrent Glioblastoma
9. Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma
10. RNA-Lipid Particle (RNA-LP) Vaccines for Recurrent Adult Glioblastoma (GBM)
11. Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas
12. Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma
13. Recurrent GBM Treated With Neurosurgical Resection and IORT Using the Xoft Axxent eBx System and Bevacizumab (IORT)
14. Testing the Ability of AMG 232 (KRT 232) to Get Into the Tumor in Patients With Brain Cancer
15. Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating Fields
16. Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells
17. A Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in the Setting of Recurrent Glioblastoma. The MOAB Trial (MOAB)
18. Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults
19. Fimepinostat in Treating Brain Tumors in Children and Young Adults (PNOC016)
20. Role of Repeat Resection in Recurrent Glioblastoma
21. Tris-CAR-T Cell Therapy for Recurrent Glioblastoma
22. Study to Evaluate the Safety and Efficacy of ASC40 Tablets in Combination With Bevacizumab in Subjects With rGBM
23. Individualized Systems Medicine Functional Profiling for Recurrent Glioblastoma (ISM-GBM)
24. RMC-5552 Monotherapy in Adult Subjects With Recurrent Glioblastoma
25. Reirradiation and Niraparib in Patients With Recurrent Glioblastoma (RiNG)
26. PARP Inhibition for Gliomas (PI-4G or π4g) (OU-SCC-PI-4G)
27. VB-111 in Surgically Accessible Recurrent/Progressive GBM
28. Feasibility of Individualized Therapy for Recurrent Glioblastoma
29. Anti-Lag-3 (Relatlinib) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma
30. Pembrolizumab in Treating Patients With Recurrent Glioblastoma
31. Chimeric Antigen Receptor (CAR) T Cells With a Chlorotoxin Tumor-Targeting Domain for the Treatment of MMP2+ Recurrent or Progressive Glioblastoma
32. Multiple Doses of Neural Stem Cell Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas
33. Study to Evaluate Ibudilast and TMZ Combo Treatment in Newly Diagnosed and Recurrent Glioblastoma
34. CARv3-TEAM-E T Cells in Glioblastoma
35. Exablate Blood-Brain Barrier Disruption With Carboplatin for the Treatment of rGBM
36. Adavosertib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma
37. Exablate Blood-Brain Barrier Disruption for the Treatment of rGBM in Subjects Undergoing Carboplatin Monotherapy
38. Cediranib Maleate and Olaparib Compared to Bevacizumab in Treating Patients With Recurrent Glioblastoma
39. A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors
40. A Study of Intra-tumoral Administered MTX110 in Patients With Recurrent Glioblastoma (MAGIC-G1)
41. The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302) (RECSUR)
42. Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma
43. MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
44. The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma (RECMAP)
45. Atezolizumab and Cabozantinib for the Treatment of Recurrent Glioblastoma
46. Studying the Safety, Efficacy, and Pharmacokinetic Characteristics of BNCT in Patients With Recurrent High-grade Gliomas
47. Standard Chemotherapy vs. Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Glioblastoma (CSCRGBM)
48. Niraparib/TTFields in GBM
49. BGB-290 and Temozolomide in Treating Patients With Recurrent Gliomas With IDH1/2 Mutations
50. Sonodynamic Therapy in Patients With Recurrent GBM (GBM 001)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.